Search Results - Anton Pozniak

Refine Results
  1. 1
    HIV Drug Resistance — An Emerging Threat to Epidemic Control

    HIV Drug Resistance — An Emerging Threat to Epidemic Control by Chris Beyrer, Anton Pozniak

    Published 2017
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break points

    Large disparities in HIV treatment cascades between eight European and high‐income countries – analysis of break points by Alice Raymond, Andrew Hill, Anton Pozniak

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs

    Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs by Mariana S. Sousa, Anton Pozniak, Marta Boffito

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Are new antiretroviral treatments increasing the risks of clinical obesity?

    Are new antiretroviral treatments increasing the risks of clinical obesity? by Andrew Hill, Laura Waters, Anton Pozniak

    Published 2019
    Get full text
    Editorial
    Save to List
    Saved in:
  5. 5
    Has the time come to abandon efavirenz for first-line antiretroviral therapy?

    Has the time come to abandon efavirenz for first-line antiretroviral therapy? by François Raffi, Anton Pozniak, M A Wainberg

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    The treatment of tuberculosis in HIV-infected persons

    The treatment of tuberculosis in HIV-infected persons by Anton Pozniak, Robert F. Miller, Peter L. Ormerod

    Published 1999
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? by Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak

    Published 2018
    Editorial
    Save to List
    Saved in:
  8. 8
    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety?

    Tenofovir alafenamide versus tenofovir disoproxil fumarate: is there a true difference in efficacy and safety? by Andrew Hill, Sophie Hughes, Dzintars Gotham, Anton Pozniak

    Published 2018
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Bacterial Vaginosis, Ethnicity, and the Use of Genital Cleaning Agents: A Case Control Study

    Bacterial Vaginosis, Ethnicity, and the Use of Genital Cleaning Agents: A Case Control Study by Sasikala Rajamanoharan, Nicola Low, Simon B. Jones, Anton Pozniak

    Published 1999
    Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Rapidly declining HIV infection in MSM in central London

    Rapidly declining HIV infection in MSM in central London by Nneka Nwokolo, Andrew Hill, Alan McOwan, Anton Pozniak

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Gonorrhoea in inner London: results of a cross sectional study

    Gonorrhoea in inner London: results of a cross sectional study by Nicola Low, Gavin Daker‐White, David H. Barlow, Anton Pozniak

    Published 1997
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics

    Episodic Sexual Transmission of HIV Revealed by Molecular Phylodynamics by Fraser Lewis, G. Hughes, Andrew Rambaut, Anton Pozniak, Andrew Brown

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP

    How safe is TDF/FTC as PrEP? A systematic review and meta-analysis of the risk of adverse events in 13 randomised trials of PrEP by Victoria Pilkington, Andrew Hill, Sophie Hughes, Nneka Nwokolo, Anton Pozniak

    Published 2018
    Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology

    Does tuberculosis accelerate the progression of HIV disease? Evidence from basic science and epidemiology by Julia del Amo, Adam S. Malin, Anton Pozniak, Kevin M. De Cock

    Published 1999
    Get full text
    Revisão
    Save to List
    Saved in:
  15. 15
    Clinical management of tuberculosis and HIV-1 co-infection

    Clinical management of tuberculosis and HIV-1 co-infection by Charlotte Schutz, Graeme Meintjes, Fahad Almajid, Robert J. Wilkinson, Anton Pozniak

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance

    Virologic Rebound on HAART in the Context of Low Treatment Adherence Is Associated With a Low Prevalence of Antiretroviral Drug Resistance by John Walsh, Anton Pozniak, Mark Nelson, Sundhiya Mandalia, Brian George Gazzard

    Published 2002
    Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis

    Clinical Characteristics of Iris Syndrome in Patients with HIV and Tuberculosis by Christos Michailidis, Anton Pozniak, Sundhiya Mandalia, Sheena Basnayake, Mark Nelson, Brian Gazzard

    Published 2005
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades

    Can the UNAIDS 90-90-90 target be achieved? A systematic analysis of national HIV treatment cascades by Jacob Levi, Alice Raymond, Anton Pozniak, Pietro Vernazza, Philipp Köhler, Andrew Hill

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy

    Comparative Safety and Neuropsychiatric Adverse Events Associated With Efavirenz Use in First-Line Antiretroviral Therapy by Nathan Ford, Zara Shubber, Anton Pozniak, Marco Vitória, Meg Doherty, Catherine Kirby, Alexandra Calmy

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  20. 20
    Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load

    Loss of blood CD11c+ myeloid and CD11c−plasmacytoid dendritic cells in patients with HIV-1 infection correlates with HIV-1 RNA virus load by Heather Donaghy, Anton Pozniak, Brian Gazzard, Nad A. Qazi, Jill Gilmour, Frances Gotch, Steven Patterson

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: